跳至主要内容
临床试验/CTRI/2019/05/019157
CTRI/2019/05/019157尚未招募Unknown

Comparative evaluation of clinical outcomes of toric Implantabe Contact Lens (ICL) versus toric Implantable Phakic Contact lens (IPCL)

Care group Sight Solution LLP1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年1月7日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1. Postoperative emmetropia

研究概览

简要总结

This is a prospective, randomized study designed to compare two types of phakic lenses; the toric ICL and the toric IPCL. The study will involve 40 eyes with high myopia with regular corneal astigmatism more than 1.25 D. These will be randomly allocated in 2 groups based on computer generated random number table. Group 1 will include 20 eyes which will undergo toric ICL implantation while Group 2 will include 20 eyes which will include 20 eyes which will undergo toric IPCL implantation. Parameters which will be assessed include uncorrected and best corrected visual acuity, keratometric and refractive cylinder, endothelial cell count, intraocular pressure, higher order aberrations, lens rotation, contrast sensitivity and glare acuity. All these investigations will be performed at baseline, 1 week, 1 month, 3 months and at 6 months follow up visit.

ii.

x.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
21.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • 40 eyes, with high myopia and regular corneal astigmatism more than 1.25 D.

排除标准

  • a) Presence of other associated ocular co-morbidities such as glaucoma, uveitis, or any posterior segment pathology.
  • b) Patients with irregular corneal astigmatism due to corneal scarring or other corneal abnormalities c) Patient not willing to participate or follow up in the study.

结局指标

主要结局

1. Postoperative emmetropia

时间窗: Baseline, 1 week, 1 month, 3 months and at 6 months

2. Phakic lens stability

时间窗: Baseline, 1 week, 1 month, 3 months and at 6 months

次要结局

  • 1. Post operative higher order aberrations(2. Contrast sensitivity and glare acuity)

研究者

发起方
Care group Sight Solution LLP
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验